Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-24
DOI
10.1038/s41375-018-0292-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
- (2018) Yingjie Nie et al. Science Signaling
- Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer
- (2018) Yingjie Nie et al. Science Signaling
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- TNFR2: A Novel Target for Cancer Immunotherapy
- (2017) Éva S. Vanamee et al. TRENDS IN MOLECULAR MEDICINE
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Soluble tumour necrosis factor receptor type II and survival in colorectal cancer
- (2016) Ana Babic et al. BRITISH JOURNAL OF CANCER
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Genomic landscape of cutaneous T cell lymphoma
- (2015) Jaehyuk Choi et al. NATURE GENETICS
- The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome
- (2015) Ana Carolina da Silva Almeida et al. NATURE GENETICS
- Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2
- (2015) Alexander Ungewickell et al. NATURE GENETICS
- Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
- (2015) Linghua Wang et al. NATURE GENETICS
- Reduction of Regulatory T Cells by Mogamulizumab, a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients with Aggressive/Refractory Mycosis Fungoides and Sezary Syndrome
- (2014) X. Ni et al. CLINICAL CANCER RESEARCH
- Targeting regulatory T cells in tumor immunotherapy
- (2014) Mark J Smyth et al. IMMUNOLOGY AND CELL BIOLOGY
- Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells
- (2014) X. Chen et al. JOURNAL OF IMMUNOLOGY
- A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma
- (2014) Ahmad A Tarhini et al. Journal of Translational Medicine
- Regulatory T cells—an important target for cancer immunotherapy
- (2014) Charles G. Drake et al. Nature Reviews Clinical Oncology
- Reducing TNF Receptor 2 + Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
- (2013) Chindu Govindaraj et al. CLINICAL CANCER RESEARCH
- Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment
- (2013) Chindu Govindaraj et al. CLINICAL IMMUNOLOGY
- TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment
- (2013) X. Chen et al. JOURNAL OF IMMUNOLOGY
- Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2
- (2013) Yoshiaki Okubo et al. Scientific Reports
- Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts
- (2012) C. S. Lee et al. BLOOD
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non-Hodgkin Lymphoma
- (2012) C. Heemann et al. CLINICAL CANCER RESEARCH
- Targeting Regulatory T Cells in Cancer
- (2011) W. L. Byrne et al. CANCER RESEARCH
- Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
- (2010) K. Klages et al. CANCER RESEARCH
- Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+regulatory T cells in human peripheral blood
- (2010) Xin Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Decrease of CD4+CD25+ regulatory T cells and TGF-β at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation
- (2010) Qing Li et al. LEUKEMIA RESEARCH
- Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis
- (2008) Weici Zhang et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search